Pfizer leans on cost cuts to offset falling revenue
By Bhanvi Satija and Michael Erman (Reuters) -Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research operations, highlighting its operational efficiency even as it reported lower first-quarter revenue due to declining sales of its COVID-19 treatment Paxlovid. Chief Executive Albert Bourla, speaking on a …
Pfizer leans on cost cuts to offset falling revenue Read More »










